Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells
Leigh A. Stoddart(University of Glasgow), Stephen J. Hill(University of Nottingham), Albert J. Kooistra(Covance (United States)), Barrie Kellam(University of Nottingham), Andrea J. Vernall(University of Nottingham), Henry F. Vischer(Vrije Universiteit Amsterdam), Reggie Bosma(Vrije Universiteit Amsterdam), Stephen J. Briddon(University of Nottingham), Mónica Bouzo-Lorenzo(Complejo Hospitalario Universitario de Santiago), Rob Leurs(Vrije Universiteit Amsterdam), Chris de Graaf(Uppsala University)
Cited by 62
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
GPCRdb in 2021: integrating GPCR sequence, structure and function
|Nucleic Acids Research|2020|377
GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources
|Nucleic Acids Research|2022|212
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling
|Molecular Pharmacology|2003|187
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
|Pharmacological Reviews|2021|149